NCT02064114View on ClinicalTrials.gov

SORT - AF Supervised Obesity Reduction Trial for AF Ablation Patients

NACompletedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

January 16, 2020

Study Completion Date

January 16, 2020

Conditions
Atrial FibrillationObesitySleep Apnea
Interventions
PROCEDURE

Intervention group

Start of optimal management of risk factors, every 2 weeks for 6 months after atrial fibrillation ablation. And followed for a period of 3,6 and 12 months after the procedure.

PROCEDURE

control group

Followed for a period of 3,6 and 12 months after the procedure.

Trial Locations (4)

20246

Asklepios ST. Georg, Hamburg

Universitätsklinikum Hamburg-Eppendorf, Hamburg

23562

Universitäres Herzzentrum Lübeck, Lübeck

Unknown

Herzzentrum der Universität zu Köln, Cologne

Sponsors

Collaborators (1)

Abbott Medical Devices
All Listed Sponsors
collaborator

Abbott Medical Devices

INDUSTRY

collaborator

Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)

OTHER

lead

Universitätsklinikum Hamburg-Eppendorf

OTHER